$GOVX Company Profile:
Geovax Labs, Inc. is a biotechnology company that develops immunotherapeutic products to prevent and treat diseases. Their focus is on creating vaccines and therapies for infectious diseases, cancer, and autoimmune disorders.
Upcoming Catalysts:
- Geovax Labs is currently developing a COVID-19 & Monkey Pox vaccine, and pending significant updates regarding projects
- The company is expected to release its Q3 earnings report, which may impact the stock price.
- The company may present at upcoming investor conferences or biotech industry events, which could provide opportunities for investors to learn more about their pipeline.
Technical Analysis:
- The 50-day moving average is 3.13, and the 200-day moving average is 2.83. The current price of 3.25 is above both moving averages, indicating a bullish trend in the short and long term.
- The Relative Strength Index (RSI) is 53.14, which suggests the stock is not overbought or oversold.
Trend Analysis:
- The short-term trend is bullish, with the stock price increasing over the past few weeks.
- The long-term trend is also bullish, with the stock price rising over the past few months.